A muscle growth-promoting treatment based on the attenuation of activin/myostatin signalling results in long-term testicular abnormalities
Activin/myostatin signalling acts to induce skeletal muscle atrophy in adult mammals by inhibiting protein synthesis as well as promoting protein and organelle turnover. Numerous strategies have been successfully developed to attenuate the signalling properties of these molecules, which result in au...
Main Authors: | Danielle Vaughan, Robert Mitchell, Oliver Kretz, David Chambers, Maciej Lalowski, Helge Amthor, Olli Ritvos, Arja Pasternack, Antonios Matsakas, Sakthivel Vaiyapuri, Tobias B. Huber, Bernd Denecke, Abir Mukherjee, Darius Widera, Ketan Patel |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2021-02-01
|
Series: | Disease Models & Mechanisms |
Subjects: | |
Online Access: | http://dmm.biologists.org/content/14/2/dmm047555 |
Similar Items
-
Inhibition of Activin/Myostatin signalling induces skeletal muscle hypertrophy but impairs mouse testicular development
by: Danielle Vaughan, et al.
Published: (2020-01-01) -
Diminution in sperm quantity and quality in mouse models of Duchenne Muscular Dystrophy induced by a myostatin-based muscle growth-promoting intervention
by: Danielle Vaughan, et al.
Published: (2020-06-01) -
Myostatin/Activin-A Signaling in the Vessel Wall and Vascular Calcification
by: Pasquale Esposito, et al.
Published: (2021-08-01) -
Myostatin and activin blockade by engineered follistatin results in hypertrophy and improves dystrophic pathology in mdx mouse more than myostatin blockade alone
by: Andrea Iskenderian, et al.
Published: (2018-10-01) -
Activin Receptor Ligand Blocking and Cancer Have Distinct Effects on Protein and Redox Homeostasis in Skeletal Muscle and Liver
by: Jaakko Hentilä, et al.
Published: (2019-01-01)